Thomas Gould (Cork North Central, Sinn Fein) | Oireachtas source

Research from the International Federation of Pharmaceutical Manufacturers and Associations, IFPMA, has found that the protocol creates a transactional framework for sharing pathogens and undermines global health security. Will researchers here need a permit to access the State's biodiversity for research and development under the protocol? What protections are we taking to avoid the consequences warned about by the IFPMA?